Leiden Bio Science Park (LBSP) had the honor of hosting a Swiss delegation, organized by Roche, Novartis, Rijksdienst voor Ondernemend Nederland, Health Holland, and other partners. The visit showcased the innovative collaborations and research driving advancements in health and life sciences.
The program included several highlights:
The delegation visited fundamental LBSP locations, including:
They introduced presentations from:
These presentations highlighted the diverse health-focused initiatives thriving at LBSP.
The day concluded with a presentation by Thomas Hankemeier on the ExposomeScan, a revolutionary tool connecting environmental factors to medical insights, paving the way for improved health research.
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL...
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by...
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.